음압창상 치료 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of negative pressure wound therapy Market

The global negative pressure wound therapy market size was valued at USD 3.00 billion in 2025 and is projected to reach USD 3.23 billion in 2026 and USD 5.80 billion by 2034, exhibiting a CAGR of 7.59% during 2026-2034. North America dominated the global market with a 39.89% market share in 2025, supported by high healthcare spending, a large chronic wound patient population, and strong adoption of advanced wound care technologies.

Negative pressure wound therapy (NPWT), also known as vacuum-assisted closure, is a wound dressing technology that applies continuous or intermittent negative pressure to the wound surface. The therapy is widely used for acute and chronic wounds, including diabetic foot ulcers, pressure ulcers, burns, trauma wounds, and postoperative wounds. NPWT systems include conventional and single-use devices, with treatment selection depending on wound size, location, patient health, and nutritional condition.

Negative Pressure Wound Therapy Market Trends

A major negative pressure wound therapy market trend is the increasing adoption of portable and single-use NPWT devices. These systems provide cost efficiency, mobility, and suitability for homecare treatment, particularly for low-to-moderately exuding wounds. The shift from hospital-based treatment toward outpatient and homecare settings across developed countries is creating new opportunities for manufacturers.

Technological advancement is another important trend. Manufacturers are developing advanced pumps, improved drapes, portable systems, and hybrid NPWT technologies designed to improve patient comfort and wound-healing outcomes.

Negative Pressure Wound Therapy Market Drivers

The increasing prevalence of chronic wounds is a major market driver. Diabetes, aging populations, reduced mobility, and related complications are increasing the number of patients suffering from diabetic foot ulcers and pressure ulcers. The growing number of surgical procedures worldwide is also increasing the prevalence of surgical wounds and supporting NPWT adoption.

The launch of technologically advanced NPWT products is further contributing to market growth. Advanced devices can support treatment in outpatient and homecare environments while providing greater portability and operational efficiency.

Market Restraints and Challenges

The availability of alternative wound-care treatments at comparatively lower costs remains a significant market restraint. High treatment costs, limited reimbursement coverage, and inadequate reimbursement policies in certain regions can restrict the adoption of NPWT systems. These challenges are particularly relevant in developing markets where healthcare budgets and access to advanced wound-care technologies remain limited.

Market Opportunities

The growing demand for homecare wound treatment represents a major market opportunity. Increasing adoption of single-use and portable NPWT systems can expand treatment beyond hospitals and clinics. Emerging countries also offer opportunities as manufacturers strengthen distribution networks and introduce cost-efficient wound-care technologies.

Segmentation Analysis

By Device Type, the market is divided into conventional NPWT and single-use NPWT. Single-use NPWT is expected to grow at a faster pace because of its portability, cost efficiency, and increasing use in homecare settings.

By Indication, diabetic foot ulcers accounted for the largest market share, supported by the rising prevalence of diabetes and related complications. Burns and trauma and pressure ulcers are also important application areas.

By End User, hospitals held the dominant market position due to the large number of acute and chronic wound patients treated in hospital settings. Homecare settings are expected to gain importance as portable NPWT devices become more widely available.

Regional Analysis

North America generated USD 738.1 million in 2025, maintaining its leading position with a 39.89% share. High spending on chronic wound treatment, advanced healthcare infrastructure, and increasing demand for wound-care technologies support regional growth.

Europe is expected to grow at a comparatively lower pace because of reimbursement limitations in countries such as France, Spain, and Italy.

Asia Pacific is projected to register a significant growth rate during the forecast period, driven by increasing chronic diseases, diabetes prevalence, healthcare investments, and a growing patient population.

Latin America and the Middle East & Africa are expected to witness moderate growth because of treatment costs and limited reimbursement support.

Key Industry Players

Leading companies operating in the negative pressure wound therapy market include Smith & Nephew, KCI Licensing, Inc., ConvaTec Inc., Cardinal Health, Medela AG, Molnlycke Health Care AB, Talley Group Ltd, PAUL HARTMANN Asia-Pacific Ltd., and Lohmann & Rauscher GmbH & Co. KG.

Recent Industry Developments

Recent industry developments include ExtriCARE USA's introduction of hybrid NPWT technology, Medela's innovative technology contract with Vizient for its Invia systems, and KCI Licensing, Inc.'s U.S. FDA 510(k) clearance for its DERMATAC silicone-acrylic hybrid drape.

Investment Analysis and Opportunities

The negative pressure wound therapy market research report presents attractive investment opportunities through portable NPWT, single-use systems, homecare applications, and advanced wound-care technologies. Companies investing in product innovation, emerging-market distribution, and cost-efficient treatment solutions can strengthen their competitive positions.

Conclusion

The global negative pressure wound therapy market is positioned for steady expansion from USD 3.00 billion in 2025 to USD 3.23 billion in 2026 and USD 5.80 billion by 2034. Rising chronic wound prevalence, increasing surgical procedures, technological innovation, and growing homecare adoption are key factors supporting market growth. Although high treatment costs and reimbursement limitations remain challenges, the increasing demand for portable, single-use, and technologically advanced NPWT solutions is expected to create significant market opportunities across developed and emerging healthcare markets.

Unit Value (USD billion)

By Device Type

• Conventional NPWT
• Single-use NPWT

By Indication

• Diabetic Foot Ulcers
• Pressure Ulcers
• Burns & Trauma
• Others

By End User

• Hospitals
• Clinics
• Homecare Settings
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Diabetic Foot Ulcers, for Key Country/ Regions, 2025
• 4.2. Technological Advancements in NPWT, by Key Players
• 4.3. Detail Product Mapping, for Key Players
• 4.4. Pricing Analysis, by Key Players in Key Countries/Regions
• 4.5. Key Industry Developments - Partnerships, Mergers and Acquisitions

5. Global Negative Pressure Wound Therapy (NPWT) Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Device Type
  • 5.2.1. Conventional NPWT
  • 5.2.2. Single-use NPWT
• 5.3. Market Analysis, Insights and Forecast - By Indication
  • 5.3.1. Diabetic Foot Ulcers
  • 5.3.2. Pressure Ulcers
  • 5.3.3. Burns & Trauma
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Clinics
  • 5.4.3. Homecare Settings
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Negative Pressure Wound Therapy (NPWT) Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Device Type
  • 6.2.1. Conventional NPWT
  • 6.2.2. Single-use NPWT
• 6.3. Market Analysis, Insights and Forecast - By Indication
  • 6.3.1. Diabetic Foot Ulcers
  • 6.3.2. Pressure Ulcers
  • 6.3.3. Burns & Trauma
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Clinics
  • 6.4.3. Homecare Settings
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Negative Pressure Wound Therapy (NPWT) Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Device Type
  • 7.2.1. Conventional NPWT
  • 7.2.2. Single-use NPWT
• 7.3. Market Analysis, Insights and Forecast - By Indication
  • 7.3.1. Diabetic Foot Ulcers
  • 7.3.2. Pressure Ulcers
  • 7.3.3. Burns & Trauma
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Clinics
  • 7.4.3. Homecare Settings
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia pacific Negative Pressure Wound Therapy (NPWT) Market Analysis, Insights and Forecast, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Device Type
  • 8.2.1. Conventional NPWT
  • 8.2.2. Single-use NPWT
• 8.3. Market Analysis, Insights and Forecast - By Indication
  • 8.3.1. Diabetic Foot Ulcers
  • 8.3.2. Pressure Ulcers
  • 8.3.3. Burns & Trauma
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Clinics
  • 8.4.3. Homecare Settings
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Negative Pressure Wound Therapy (NPWT) Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Device Type
  • 9.2.1. Conventional NPWT
  • 9.2.2. Single-use NPWT
• 9.3. Market Analysis, Insights and Forecast - By Indication
  • 9.3.1. Diabetic Foot Ulcers
  • 9.3.2. Pressure Ulcers
  • 9.3.3. Burns & Trauma
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Clinics
  • 9.4.3. Homecare Settings
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Negative Pressure Wound Therapy (NPWT) Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Device Type
  • 10.2.1. Conventional NPWT
  • 10.2.2. Single-use NPWT
• 10.3. Market Analysis, Insights and Forecast - By Indication
  • 10.3.1. Diabetic Foot Ulcers
  • 10.3.2. Pressure Ulcers
  • 10.3.3. Burns & Trauma
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Clinics
  • 10.4.3. Homecare Settings
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Company Profiles
  • 11.3.1. Smith & Nephew
    • 11.3.1.1. Overview
    • 11.3.1.2. Products & Services
    • 11.3.1.3. SWOT Analysis
    • 11.3.1.4. Recent Developments
    • 11.3.1.5. Strategies
    • 11.3.1.6. Financials (Based on Availability)
  • 11.3.2. KCI Licensing, Inc.
    • 11.3.2.1. Overview
    • 11.3.2.2. Products & Services
    • 11.3.2.3. SWOT Analysis
    • 11.3.2.4. Recent Developments
    • 11.3.2.5. Strategies
    • 11.3.2.6. Financials (Based on Availability)
  • 11.3.3. ConvaTec Inc.
    • 11.3.3.1. Overview
    • 11.3.3.2. Products & Services
    • 11.3.3.3. SWOT Analysis
    • 11.3.3.4. Recent Developments
    • 11.3.3.5. Strategies
    • 11.3.3.6. Financials (Based on Availability)
  • 11.3.4. Cardinal Health
    • 11.3.4.1. Overview
    • 11.3.4.2. Products & Services
    • 11.3.4.3. SWOT Analysis
    • 11.3.4.4. Recent Developments
    • 11.3.4.5. Strategies
    • 11.3.4.6. Financials (Based on Availability)
  • 11.3.5. Medela AG
    • 11.3.5.1. Overview
    • 11.3.5.2. Products & Services
    • 11.3.5.3. SWOT Analysis
    • 11.3.5.4. Recent Developments
    • 11.3.5.5. Strategies
    • 11.3.5.6. Financials (Based on Availability)
  • 11.3.6. Molnlycke Health Care AB
    • 11.3.6.1. Overview
    • 11.3.6.2. Products & Services
    • 11.3.6.3. SWOT Analysis
    • 11.3.6.4. Recent Developments
    • 11.3.6.5. Strategies
    • 11.3.6.6. Financials (Based on Availability)
  • 11.3.7. Talley Group Ltd
    • 11.3.7.1. Overview
    • 11.3.7.2. Products & Services
    • 11.3.7.3. SWOT Analysis
    • 11.3.7.4. Recent Developments
    • 11.3.7.5. Strategies
    • 11.3.7.6. Financials (Based on Availability)
  • 11.3.8. PAUL HARTMANN Asia-Pacific Ltd.
    • 11.3.8.1. Overview
    • 11.3.8.2. Products & Services
    • 11.3.8.3. SWOT Analysis
    • 11.3.8.4. Recent Developments
    • 11.3.8.5. Strategies
    • 11.3.8.6. Financials (Based on Availability)
  • 11.3.9. Lohmann & Rauscher GmbH & Co. KG
    • 11.3.9.1. Overview
    • 11.3.9.2. Products & Services
    • 11.3.9.3. SWOT Analysis
    • 11.3.9.4. Recent Developments
    • 11.3.9.5. Strategies
    • 11.3.9.6. Financials (Based on Availability)
  • 11.3.10. Other Players
    • 11.3.10.1. Overview
    • 11.3.10.2. Products & Services
    • 11.3.10.3. SWOT Analysis
    • 11.3.10.4. Recent Developments
    • 11.3.10.5. Strategies
    • 11.3.10.6. Financials (Based on Availability)

12. Strategic Recommendations